Pando Bioscience
New accelerator entry · 2023-02-09 · the record
In their words
Pando is an AI-driven synthetic biology company revolutionizing enzyme engineering for the pharmaceutical industry. Our ultra-high-throughput screening platform screens 1000-fold more enzymes 75% faster and 80% cheaper than traditional methods. This empowers our generative AI to efficiently optimize enzymes across multiple properties, delivering high-performing, tailored enzymes that reduce costs and enhance efficiency.
What the record says
- One of 34 companies held here in Healthcare › Industrial Bio.
No investor is drawn from a Form D — the form states how many invested and never who. The one investor on this graph is named because a batch has exactly one.
The full profile
Source Check, INVEST, RECRUIT and Press Requests on Pando Bioscience
- Source Check — verify what Pando Bioscience states, against the registers that hold it.
- INVEST — size up this company on the figures its record states.
- RECRUIT — see who is already on the team.
- Press Requests — connect with Pando Bioscience for a story.
You land back on this company when you are in.
Not ready to upgrade? Keep this one in view instead.
Watchlist Pando BioscienceYou get an alert in MentionFox the next time this company shows up.
Is this you?
If you're behind Pando Bioscience: acceptance into a YC batch is one of the few weeks a young company gets looked up by people who matter — investors, other founders, press. FoxPlug turns the commits, deploys, and releases you're already making into that story automatically, so anyone who looks finds something current. FoxChat puts a guide on your own site so the people YC's own page just sent you don't read one line and leave.
Sourced from the company's Y Combinator directory entry.